Skip to main content
Top
Published in: Tumor Biology 2/2015

01-02-2015 | Research Article

Comparative proteomic analysis of fibrosarcoma and skin fibroblast cell lines

Authors: Ogunc Meral, Hamdi Uysal

Published in: Tumor Biology | Issue 2/2015

Login to get access

Abstract

Comparative proteomic analysis of normal and cancer cell lines provides for a better understanding of the molecular mechanism of cancer development and is essential for developing more effective strategies for new biomarker or drug target discovery. The purpose of this study is to compare protein expression levels between fibrosarcoma and fibroblast cell lines. In our study, two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) techniques were carried out to compare the protein profile between fibrosarcoma and fibroblast cell lines. We prepared cell lysate samples to analyze intracellular proteins and secretome samples to analyze extracellular proteins in both cell lines. Our results revealed 13 upregulated proteins and 1 downregulated protein of which all of them identified in fibrosarcoma cell line after the comparison with fibroblast cell line cell lysates. When comparing secretome profiles of both cell lines, we found and identified 13 proteins only expressed in fibrosarcoma cell line. These identified proteins have common functions such as cell proliferation, cell differentiation, invasion, metastasis, and apoptosis in cancer. The data obtained from this study indicates that these proteins have importance on understanding the molecular mechanism of fibrosarcoma. These proteins may serve as candidate biomarkers and drug targets for future clinical studies.
Literature
1.
go back to reference Fletcher CDM, Krishnan Unni K, Mertens F. Pathology and genetics of tumours of soft tissue and bone. 3rd ed. Lyon: IARC; 2006. Fletcher CDM, Krishnan Unni K, Mertens F. Pathology and genetics of tumours of soft tissue and bone. 3rd ed. Lyon: IARC; 2006.
2.
go back to reference Nikitovic D, Kouvidi K, Karamanos NK, Tzanakakis GN. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. Biomed Res Int. 2013;2013:929531.CrossRefPubMedPubMedCentral Nikitovic D, Kouvidi K, Karamanos NK, Tzanakakis GN. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. Biomed Res Int. 2013;2013:929531.CrossRefPubMedPubMedCentral
4.
go back to reference Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier Saunders; 2013. Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier Saunders; 2013.
5.
go back to reference Song B, Kim B, Choi SH, Song KY, Chung YG, Lee YS, et al. Mesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cells. Korean J Pathol. 2014;48(3):217–24.CrossRefPubMedPubMedCentral Song B, Kim B, Choi SH, Song KY, Chung YG, Lee YS, et al. Mesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cells. Korean J Pathol. 2014;48(3):217–24.CrossRefPubMedPubMedCentral
6.
go back to reference Klijanienko J, Lagace R. Soft tissue tumors: a multidisciplinary, decisional diagnostic approach. 1st ed. Hoboken: Wiley; 2011.CrossRef Klijanienko J, Lagace R. Soft tissue tumors: a multidisciplinary, decisional diagnostic approach. 1st ed. Hoboken: Wiley; 2011.CrossRef
8.
go back to reference Zwickl H, Traxler E, Staettner S, Parzefall W, Grasl-Kraupp B, Karner J, et al. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis. 2005;26:2779–85.CrossRefPubMed Zwickl H, Traxler E, Staettner S, Parzefall W, Grasl-Kraupp B, Karner J, et al. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis. 2005;26:2779–85.CrossRefPubMed
9.
go back to reference Guoqing L, Zhefeng X, Jianping L, Cui L, Feng L, Zhuchu C. Cancer: a proteomic disease. Sci China Life Sci. 2011;54:403–8. Guoqing L, Zhefeng X, Jianping L, Cui L, Feng L, Zhuchu C. Cancer: a proteomic disease. Sci China Life Sci. 2011;54:403–8.
10.
go back to reference Rubporn A, Srisomsap C, Subhasitanont P, Chokchamnankit D, Chiablaem K, Svasti J, et al. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Cancer Genomics Proteomics. 2009;6:229–37.PubMed Rubporn A, Srisomsap C, Subhasitanont P, Chokchamnankit D, Chiablaem K, Svasti J, et al. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Cancer Genomics Proteomics. 2009;6:229–37.PubMed
11.
go back to reference Zang J, Wang P, Gao S, Xiao D, Zhang J, Wang K. Differential proteins expression between gastric cancer and normal cell lines. Life Sci J. 2008;5(4):28–32. Zang J, Wang P, Gao S, Xiao D, Zhang J, Wang K. Differential proteins expression between gastric cancer and normal cell lines. Life Sci J. 2008;5(4):28–32.
12.
go back to reference Deng SS, Xing TY, Zhou HY, Xiong RH, Lu YG, Wen B, et al. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics Proteomics Bioinforma. 2006;4(3):165–72.CrossRef Deng SS, Xing TY, Zhou HY, Xiong RH, Lu YG, Wen B, et al. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics Proteomics Bioinforma. 2006;4(3):165–72.CrossRef
13.
go back to reference Johansson B, Pourian MR, Chuan Y, Byman I, Bergh A, Pang ST, et al. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy. Prostate. 2006;66:1235–44.CrossRefPubMed Johansson B, Pourian MR, Chuan Y, Byman I, Bergh A, Pang ST, et al. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy. Prostate. 2006;66:1235–44.CrossRefPubMed
14.
go back to reference Antharavally BS, Mallia KA, Rangaraj P, Haney P, Bell PA. Quantitation of proteins using a dye-metal-based colorimetric protein assay. Anal Biochem. 2009;385(2):342–5.CrossRefPubMed Antharavally BS, Mallia KA, Rangaraj P, Haney P, Bell PA. Quantitation of proteins using a dye-metal-based colorimetric protein assay. Anal Biochem. 2009;385(2):342–5.CrossRefPubMed
15.
go back to reference Shen H, Huang J, Pei H, Zeng S, Tao Y, Shen L, et al. Comparative proteomic study for profiling differentially expressed proteins between chinese left and right sided colon cancers. Cancer Sci. 2013;104(1):135–41.CrossRefPubMed Shen H, Huang J, Pei H, Zeng S, Tao Y, Shen L, et al. Comparative proteomic study for profiling differentially expressed proteins between chinese left and right sided colon cancers. Cancer Sci. 2013;104(1):135–41.CrossRefPubMed
16.
go back to reference Yang MS, Wang HS, Wang BS, Li WH, Pang ZF, Zou BK, et al. A comparative proteomic study identified calreticulin and prohibitin up-regulated in adenocortical carcinomas. Diagn Pathol. 2013;8:58.PubMedPubMedCentral Yang MS, Wang HS, Wang BS, Li WH, Pang ZF, Zou BK, et al. A comparative proteomic study identified calreticulin and prohibitin up-regulated in adenocortical carcinomas. Diagn Pathol. 2013;8:58.PubMedPubMedCentral
17.
go back to reference Coghlin C, Carpenter B, Dundas SR, Lawrie LC, Telfer C, Murray GI. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol. 2006;210:351–57.CrossRefPubMed Coghlin C, Carpenter B, Dundas SR, Lawrie LC, Telfer C, Murray GI. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol. 2006;210:351–57.CrossRefPubMed
18.
go back to reference Li C, Chen Z, Xiao Z, Wu X, Zhan X, Zhang X, et al. Comparative proteomic analysis of human lung squamous carcinoma. Biochem Biophys Res Commun. 2003;309:253–60.CrossRefPubMed Li C, Chen Z, Xiao Z, Wu X, Zhan X, Zhang X, et al. Comparative proteomic analysis of human lung squamous carcinoma. Biochem Biophys Res Commun. 2003;309:253–60.CrossRefPubMed
19.
go back to reference Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics. 2010;9(9):1873–84.CrossRefPubMedPubMedCentral Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics. 2010;9(9):1873–84.CrossRefPubMedPubMedCentral
20.
go back to reference Chang HY, Hor SY, Lim KP, Zain RB, Cheong SC, Rahman MA, et al. Oral cancer secretome: identification of cancer associated proteins. Electrophoresis. 2013;34(15):2199–208.CrossRefPubMed Chang HY, Hor SY, Lim KP, Zain RB, Cheong SC, Rahman MA, et al. Oral cancer secretome: identification of cancer associated proteins. Electrophoresis. 2013;34(15):2199–208.CrossRefPubMed
21.
go back to reference Dos Santos M, Da Cunha Mercante AM, Nunes FD, Leopoldino AM, De Carvalho MB, Gazito D, et al. Prognostic significance of ndrg1 expression in oral and oropharyngeal squamous cell carcinoma. Mol Biol Rep. 2012;39(12):10157–65.CrossRefPubMed Dos Santos M, Da Cunha Mercante AM, Nunes FD, Leopoldino AM, De Carvalho MB, Gazito D, et al. Prognostic significance of ndrg1 expression in oral and oropharyngeal squamous cell carcinoma. Mol Biol Rep. 2012;39(12):10157–65.CrossRefPubMed
22.
go back to reference Pino I, Pio R, Toledo G, Zabalegui N, Vicent S, Rey N, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer. 2003;41(2):131–43.CrossRefPubMed Pino I, Pio R, Toledo G, Zabalegui N, Vicent S, Rey N, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer. 2003;41(2):131–43.CrossRefPubMed
23.
go back to reference Chaker S, Kashat L, Voisin S, Kaur J, Kak I, Macmillan C, et al. Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas. Proteomics. 2013;13(5):771–87.CrossRefPubMed Chaker S, Kashat L, Voisin S, Kaur J, Kak I, Macmillan C, et al. Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas. Proteomics. 2013;13(5):771–87.CrossRefPubMed
24.
go back to reference Ito K, Stannard K, Gabutero E, Clark AM, Neo SY, Onturk S, et al. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev. 2012;31:763–78.CrossRefPubMed Ito K, Stannard K, Gabutero E, Clark AM, Neo SY, Onturk S, et al. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev. 2012;31:763–78.CrossRefPubMed
25.
go back to reference Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, et al. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res. 2010;29:59.CrossRefPubMedPubMedCentral Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, et al. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res. 2010;29:59.CrossRefPubMedPubMedCentral
26.
go back to reference Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci. 2003;94(1):43–9.CrossRefPubMed Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci. 2003;94(1):43–9.CrossRefPubMed
27.
go back to reference Ge S, Mao Y, Yi Y, Xie D, Chen Z, Xiao Z. Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblast. Exp Ther Med. 2012;3:857–60.PubMedPubMedCentral Ge S, Mao Y, Yi Y, Xie D, Chen Z, Xiao Z. Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblast. Exp Ther Med. 2012;3:857–60.PubMedPubMedCentral
28.
go back to reference Sardana G, Marshall J, Diamandis EP. Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture conditioned medium. Clin Chem. 2007;53(3):429–37.CrossRefPubMed Sardana G, Marshall J, Diamandis EP. Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture conditioned medium. Clin Chem. 2007;53(3):429–37.CrossRefPubMed
29.
go back to reference Sasaki T, Hankins GR, Helm GA. Major vault protein/lung resistance-related protein (MVP/LRP) expression in nervous system tumors. Brain Tumor Pathol. 2002;19(2):59–62.CrossRefPubMed Sasaki T, Hankins GR, Helm GA. Major vault protein/lung resistance-related protein (MVP/LRP) expression in nervous system tumors. Brain Tumor Pathol. 2002;19(2):59–62.CrossRefPubMed
30.
go back to reference Diaz-Ramos A, Roig-Borrellas A, Garcia-Melero A, Lopez-Alemany R. α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol. 2012;2012:156795.CrossRefPubMedPubMedCentral Diaz-Ramos A, Roig-Borrellas A, Garcia-Melero A, Lopez-Alemany R. α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol. 2012;2012:156795.CrossRefPubMedPubMedCentral
Metadata
Title
Comparative proteomic analysis of fibrosarcoma and skin fibroblast cell lines
Authors
Ogunc Meral
Hamdi Uysal
Publication date
01-02-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 2/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2672-8

Other articles of this Issue 2/2015

Tumor Biology 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine